Mark Fung

5.8k total citations · 2 hit papers
69 papers, 2.9k citations indexed

About

Mark Fung is a scholar working on Biochemistry, Hematology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Mark Fung has authored 69 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Biochemistry, 21 papers in Hematology and 11 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Mark Fung's work include Blood transfusion and management (25 papers), Blood groups and transfusion (15 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (11 papers). Mark Fung is often cited by papers focused on Blood transfusion and management (25 papers), Blood groups and transfusion (15 papers) and Trauma, Hemostasis, Coagulopathy, Resuscitation (11 papers). Mark Fung collaborates with scholars based in United States, Canada and United Kingdom. Mark Fung's co-authors include Aryeh Shander, John D. Roback, Sunil V. Rao, Lewis J. Kaplan, John B. Holcomb, Brenda J. Grossman, Louis M. Katz, Jeffrey L. Carson, Claudia S. Cohn and Nancy M. Heddle and has published in prestigious journals such as JAMA, The EMBO Journal and Annals of Internal Medicine.

In The Last Decade

Mark Fung

64 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*

2012 739 citations Jeffrey L. Carson, Brenda J. Grossman et al. Annals of Internal Medicine profile →
Clinical Practice Guidelines From the AABB

2016 700 citations Jeffrey L. Carson, Brenda J. Grossman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Fung United States	21	1.6k	762	754	570	408	69	2.9k
Kathryn E. Webert Canada	28	1.1k 0.7×	1.2k 1.5×	452 0.6×	438 0.8×	183 0.4×	68	2.4k
Andrew Gettinger United States	15	1.7k 1.0×	972 1.3×	899 1.2×	416 0.7×	263 0.6×	29	2.7k
Susan J Brunskill United Kingdom	34	1.1k 0.7×	947 1.2×	703 0.9×	501 0.9×	1.0k 2.6×	82	3.5k
James P. Isbister Australia	25	933 0.6×	554 0.7×	644 0.9×	463 0.8×	269 0.7×	113	2.1k
Majed A. Refaai United States	27	822 0.5×	762 1.0×	627 0.8×	273 0.5×	512 1.3×	108	3.0k
James R. Stubbs United States	22	741 0.5×	445 0.6×	810 1.1×	384 0.7×	236 0.6×	93	1.8k
Mazyar Javidroozi United States	18	852 0.5×	423 0.6×	434 0.6×	294 0.5×	240 0.6×	41	1.4k
Martin R. Schipperus Netherlands	23	592 0.4×	1.4k 1.8×	199 0.3×	234 0.4×	209 0.5×	92	2.1k
Isabel Graupera Spain	33	468 0.3×	213 0.3×	388 0.5×	186 0.3×	1.2k 3.1×	94	4.1k
Jay S. Raval United States	25	381 0.2×	338 0.4×	298 0.4×	156 0.3×	235 0.6×	102	1.4k

Countries citing papers authored by Mark Fung

Since Specialization

Citations

This map shows the geographic impact of Mark Fung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Fung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Fung more than expected).

Fields of papers citing papers by Mark Fung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Fung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Fung. The network helps show where Mark Fung may publish in the future.

Co-authorship network of co-authors of Mark Fung

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Fung. A scholar is included among the top collaborators of Mark Fung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Fung. Mark Fung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fung, Mark, et al.. (2025). Understanding Health-Related Discussions on Reddit: Development of a Topic Assignment Method and Exploratory Analysis. JMIR Formative Research. 9. e55309–e55309. 2 indexed citations

Fung, Mark, James P. AuBuchon, & Laura D. Stephens. (2024). Classification of posttransfusion adverse events using a publicly available artificial intelligence system. Transfusion. 64(4). 590–596. 8 indexed citations

Lee, Juneyoung, et al.. (2024). Factors Associated With the Recruitment of Primary Care Workforce in Rural Vermont: A Pilot Study. Cureus.

Fung, Mark, Elizabeth Montgomery, Myra L. Wilkerson, et al.. (2024). A retrospective multi-site examination of chronic kidney disease using longitudinal laboratory results and metadata to identify clinical and financial risk. BMC Nephrology. 25(1). 447–447.

Cushman‐Vokoun, Allison M., Ryan J. Schmidt, Matthew Hiemenz, et al.. (2023). A Primer on Gene Editing: What Does It Mean for Pathologists?. Archives of Pathology & Laboratory Medicine. 148(5). 515–530. 2 indexed citations

Zeller, Michelle P., et al.. (2023). Optimizing Informed Consent Discussions: Developing a Narrative for Transfusion Consent. Transfusion Medicine Reviews. 37(3). 150757–150757. 1 indexed citations

Rajbhandary, Srijana, Chester Andrzejewski, Joy Fridey, et al.. (2022). Incorporating the entity of under‐transfusion into hemovigilance monitoring: Documenting cases due to lack of inventory. Transfusion. 62(3). 540–545. 6 indexed citations

Wheeler, Allison P., Meghan Delaney, Mark Fung, et al.. (2021). Pediatric resident knowledge of transfusion medicine: Results from the BEST‐TEST3 international education needs assessment. Transfusion. 61(8). 2487–2495. 11 indexed citations

Warrington, Jill S., Jessica W. Crothers, Andrew Goodwin, et al.. (2021). All Hands-On Deck and All Decks on Hand: Surmounting Supply Chain Limitations During the COVID-19 Pandemic. Academic Pathology. 8. 2466111320–2466111320. 5 indexed citations

10.

Yazer, Mark H., Miquel Lozano, Mark Fung, et al.. (2017). An international survey on the role of the hospital transfusion committee. Transfusion. 57(5). 1280–1287. 8 indexed citations

11.

Gorlin, Jed B., et al.. (2017). Prothrombin complex concentrate for emergent reversal of warfarin: an international survey of hospital protocols. Vox Sanguinis. 112(6). 595–597. 7 indexed citations

12.

Vassallo, Ralph, Mark Fung, Paolo Rebulla, et al.. (2013). Utility of cross‐matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review. Transfusion. 54(4). 1180–1191. 29 indexed citations

13.

Carson, Jeffrey L., Brenda J. Grossman, Steven Kleinman, et al.. (2012). Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*. Annals of Internal Medicine. 157(1). 49–58. 739 indexed citations breakdown →

14.

Campbell‐Lee, Sally A., et al.. (2011). Red blood cell products: consideration of the discrepant temperature ranges permitted for storage versus transport. Transfusion. 52(1). 195–200. 7 indexed citations

15.

Roback, John D., Stephen H. Caldwell, Robertson D. Davenport, et al.. (2010). Evidence‐based practice guidelines for plasma transfusion. Transfusion. 50(6). 1227–1239. 191 indexed citations

16.

Keating, Friederike K., Mark Fung, & David J. Schneider. (2008). Induction of platelet white blood cell (WBC) aggregate formation by platelets and WBCs in red blood cell units. Transfusion. 48(6). 1099–1105. 6 indexed citations

17.

Brooks, Erin G., Bruce R. MacPherson, & Mark Fung. (2008). Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions. Transfusion. 48(10). 2159–2166. 28 indexed citations

18.

Fung, Mark, Kendall P. Crookston, Ronald E. Domen, et al.. (2007). A proposal for curriculum content in transfusion medicine and blood banking education in pathology residency programs. Transfusion. 47(10). 1930–1936. 15 indexed citations

19.

Smith, Brian R., Alan Wells, C. Bruce Alexander, et al.. (2006). Curriculum Content and Evaluation of Resident Competency in Clinical Pathology (Laboratory Medicine)**. PubMed. 125(suppl_1). S3–S37. 10 indexed citations

20.

Fung, Mark, et al.. (2002). Evaluation of the Wampole Laboratories ELISA-based assay for Epstein–Barr virus serology. Clinica Chimica Acta. 319(1). 43–48. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact